Land: Storbritannien
Sprog: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Budesonide
Orion Pharma (UK) Ltd
R03BA02
Budesonide
100microgram/1dose
Inhalation powder
Inhalation
No Controlled Drug Status
Caution - AMP level prescribing advised
BNF: 03020000; GTIN: 6432100007926
1 Scan this code or visit www.oeh.fi/uk to see instructions on how to use Easyhaler PACKAGE LEAFLET: INFORMATION FOR THE USER EASYHALER BUDESONIDE 100 MICROGRAMS/DOSE EASYHALER BUDESONIDE 200 MICORGRAMS/DOSE EASYHALER BUDESONIDE 400 MICROGRAMS/DOSE INHALATION POWDER Budesonide READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Easyhaler Budesonide is and what it is used for 2. What you need to know before you use Easyhaler Budesonide 3. How to use Easyhaler Budesonide 4. Possible side effects 5. How to store Easyhaler Budesonide 6. Contents of the pack and other information 1. WHAT EASYHALER BUDESONIDE IS AND WHAT IT IS USED FOR The active ingredient in Easyhaler Budesonide is budesonide. Budesonide powder is packed in an inhaler. You inhale the powder into your lungs through the mouthpiece of the inhaler. Budesonide works by reducing and preventing swelling and inflammation in your lungs. Easyhaler Budesonide is a medicine called “ PREVENTER ”. It is used to prevent symptoms of asthma. It belongs to a group of medicines called corticosteroids. Budesonide will NOT stop an asthma attack that has already started. Therefore you always need to have a fast acting bronchodilating “ RELIEVER” (a beta 2 -agonist) with you. The effect of budesonide may be noticeable after a few days treatments but will only reach its maximum after a few weeks. You should use Easyhaler Budesonide regularly to prevent the asthmatic inflammation. Go on taking this medicine regularly according to instructions, Læs hele dokumentet
OBJECT 1 EASYHALER BUDESONIDE 100 MCG Summary of Product Characteristics Updated 06-Jul-2017 | Orion Pharma (UK) Limited 1. Name of the medicinal product Easyhaler Budesonide 100 micrograms/dose inhalation powder. 2. Qualitative and quantitative composition One metered dose contains 100 micrograms of budesonide. With the Easyhaler device the delivered dose (ex-actuator) contains the same quantity of active substance as the metered dose (ex-reservoir). Excipient with known effect: Lactose monohydrate. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Inhalation powder. White or almost white powder. 4. Clinical particulars 4.1 Therapeutic indications Treatment of mild, moderate, and severe persistent asthma. (Note: Easyhaler Budesonide is not suitable for the treatment of acute asthma attacks.) 4.2 Posology and method of administration Posology The therapeutic effect begins after a few days´ treatment and reaches its maximum after some weeks of treatment. When transferring a patient to Easyhaler Budesonide from other inhalation devices, the treatment should be individualised. The previous active substance, dose regimen, and method of delivery should be considered. The patients should be prescribed a starting dose of inhaled budesonide which is appropriate for the severity or level of control of their disease. The dose should be adjusted until control is achieved and then titrated to the lowest dose at which effective control of asthma is maintained. THE STARTING DOSE for adults (including the elderly and adolescents 12 to 17 years) with mild asthma (Step 2) and for children 6 to 11 years of age is 200-400 micrograms/day. If needed, the dose can be increased up to 800 micrograms/day. For adult patients with moderate (Step 3) and severe (Step 4) asthma the starting dose can be up to 1600 micrograms/day. The maintenance dose should be adjusted to meet the requirements of an individual patient taking into account the severity of the disease and the clinical response of the patient. TWICE DAILY DOS Læs hele dokumentet